Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Zhong‐Yi Dong, Wen‐Zhao Zhong, Xu‐Chao Zhang, Jian Su, Zhi Xie, Si‐Yang Maggie Liu, Hai‐Yan Tu, Hua‐Jun Chen, Yue‐Li Sun, Qing Hua Zhou, Jin‐Ji Yang, Xue‐Ning Yang, Jiaxin Lin, Hong‐Hong Yan, Hao-Ran Zhai, Li‐Xu Yan, Ri-Qiang Liao, Si-Pei Wu, Yi-Long Lung Cancer Wu
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1158/1078-0432.ccr-16-2554
- Published
- Dec 30, 2016
- Venue
- Clinical Cancer Research
- DOI
- 10.1158/1078-0432.ccr-16-2554
- PubMed
- 28039262
- Categories
- Cancer Immunotherapy and Biomarkers
- Provenance
- openalex